Jiangsu Provincial Center for Disease Control and Prevention, Nanjing, China.
Department of Hepatology, The Second Hospital of Nanjing, Nanjing University of Chinese Medicine, Nanjing, China.
BMC Public Health. 2021 Jul 7;21(1):1338. doi: 10.1186/s12889-021-11387-3.
Adverse events following immunization is an important factor influencing public trust in vaccination. Publicizing its incidence timely can increase public trust. The aim of this study is to describe the incidence and characteristics of adverse events following immunization in Jiangsu province of China from 2015 to 2018.
All information of adverse events following immunization (AEFIs) was gained from Jiangsu Province Vaccination Integrated Service Management Information System. The reported AEFI trend was analyzed using Chi-square test.
A total of 77,980 AEFI cases were reported through the AEFI system; Among which, 77,731 were classified as non-serious AEFI cases and 249 were serious AEFI cases. The male to female ratio was 1.31:1, cases less than 7 years old accounted for 97.7%. The total estimated AEFI rate was 62.70/100,000 doses. By severity, 60.75/100,000, 4.46/100,000 and 0.11/100,000 AEFI cases were common vaccine reaction, rare vaccine reaction, and serious rare vaccine reaction, respectively. The top two serious AEFI were thrombocytopenic purpura and febrile. The incidence rates showed the increasing trend and the linear trend of the increasing incidence rates passed the significant test at 0.05 levels.
The sensitivity of AEFI monitoring in Jiangsu Province is increasing and higher than the national average and most countries. The majority of AEFI cases were common adverse reactions, while the serious vaccine reactions caused by vaccines were extremely low. To elevate the sensitivity of AEFI surveillance may reduce the incidence of developing serious AEFI cases.
疫苗接种不良反应是影响公众对接种疫苗信任度的重要因素。及时公布其发生率可以增加公众的信任度。本研究旨在描述 2015 年至 2018 年中国江苏省疫苗接种不良反应的发生率和特征。
从江苏省预防接种综合服务管理信息系统中获取所有疫苗接种不良反应(AEFI)信息。采用卡方检验分析报告的 AEFI 趋势。
通过 AEFI 系统共报告了 77980 例 AEFI 病例;其中,77731 例为非严重 AEFI 病例,249 例为严重 AEFI 病例。男女比例为 1.31:1,7 岁以下病例占 97.7%。总估计 AEFI 发生率为 62.70/10 万剂。按严重程度分类,60.75/10 万、4.46/10 万和 0.11/10 万的 AEFI 分别为常见疫苗反应、罕见疫苗反应和严重罕见疫苗反应。两种最严重的 AEFI 是血小板减少性紫癜和发热。发生率呈上升趋势,上升趋势的线性趋势在 0.05 水平通过显著检验。
江苏省 AEFI 监测的敏感性在增加,且高于全国平均水平和大多数国家。大多数 AEFI 病例为常见不良反应,而疫苗引起的严重疫苗反应极为罕见。提高 AEFI 监测的敏感性可能会降低严重 AEFI 病例的发生率。